The antiphospholipid antibody syndrome (APS) is a clinical-pathologic correlation that includes a clinical event (e.g. thrombosis, pregnancy loss, thrombocytopenia) and persistent positive antiphospholipid antibodies (IgM or IgG ACA >40 MPL/GPL,IgM or IgG anti-b2GPI antibodies or a lupus anticoagulant). International consensus guidelines for APS suggest waiting at least 12 weeks before retesting to confirm antibody persistence. The Systemic Lupus International Collaborating Clinics immunological classification criteria for systemic lupus erythematosus (SLE) include testing for isotype IgA, which has yet to be incorporated into APS criteria. Low level antiphospholipid antibodies may sometimes be detected in the setting of infection, drug therapy or aging.

What is Babesia microti p32 – IgM? Babesia microti is a microscopic parasite that infects red blood cells and causes babesiosis, a malaria-like illness transmitted primarily by Ixodes scapularis ticks (also known as black-legged or deer ticks). This is the same tick species that spreads Lyme disease and anaplasmosis. The p32 – IgM test detects early immune response to a specific protein (p32) found on Babesia microti. IgM antibodies are typically the first antibodies your immune system produces after exposure to an infection, usually appearing within the first 1 to 2 weeks. Therefore, a positive or elevated result suggests a recent or active Babesia infection.

What is Babesia microti p41 – IgM? Babesia microti is a microscopic parasite that infects red blood cells and causes babesiosis, a tick-borne illness often compared to malaria due to its similar symptoms. It is primarily transmitted by the Ixodes scapularis tick (also known as the deer tick), which also carries Lyme disease and other co-infections. The p41 – IgM test detects early immune activity against a specific protein (p41) expressed by Babesia microti. IgM antibodies are the first type of antibodies produced by the immune system following infection. The presence of IgM typically indicates a recent or active infection, particularly during the early stages when symptoms first appear.

Babesia microti, the primary agent of human babesiosis in the United States. The B. microti life cycle involves two hosts, which includes a rodent, primarily the white-footed mouse, Peromyscus leucopus, and a tick in the genus, Ixodes, the same tick species that vectors Lyme disease. Cases of babesiosis caused by B. microti occur in southern New England and the northern Midwest. Early clinical manifestations are intermittent fevers accompanied by fatigue and malaise, headache, chills, and myalgias. Nausea, vomiting, reduced appetite, and depression can also occur. Coinfection with Lyme disease or anaplasmosis may complicate the clinical presentation and predispose the patient to more severe disease.